Milprosa FDA Approval History
Last updated by Judith Stewart, BPharm on June 24, 2020.
FDA Approved: Yes (First approved April 29, 2020)
Brand name: Milprosa
Generic name: progesterone
Dosage form: Vaginal Ring
Company: Ferring Pharmaceuticals Inc.
Treatment for: Female Infertility
Milprosa (progesterone) vaginal system is indicated to support embryo implantation and early pregnancy (up to 10 weeks post-embryo transfer) by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment program for infertile women.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
